Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kehao Zhao

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Molecular Cell|May 10, 2011
Histone methylation by PRC2 is inhibited by active chromatin marksFrank W Schmitges, Archana B Prusty, Mahamadou Faty, et al.
Nature Communications|October 17, 2015
Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53Qi Fei, Ke Shang, Jianhua Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 5, 2025
Discovery of a Potent and Selective TEAD Degrader with Durable Degradation ActivityLinhui Cao, Jing Yang, Yuhang Liu, et al.
Plos One|January 11, 2017
Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EEDLing Li, Hailong Zhang, Man Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferationWei Qi, HoMan Chan, Lin Teng, et al.
Cancer Research|August 28, 2013
NSD2 is recruited through its PHD domain to oncogenic gene loci to drive multiple myelomaZheng Huang, Haiping Wu, Shannon Chuai, et al.
Journal of Medicinal Chemistry|December 20, 2016
Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) MethyltransferaseAndreas Lingel, Martin Sendzik, Ying Huang, et al.
Cell Research|August 5, 2024
SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinomaBisi Miao, Ling Ge, Chenxi He, et al.
Journal of Medicinal Chemistry|December 16, 2017
Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3)H Ümit Kaniskan, Mohammad S Eram, Kehao Zhao, et al.
Angewandte Chemie (International Ed. in English)|March 3, 2015
A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)H Ümit Kaniskan, Magdalena M Szewczyk, Zhengtian Yu, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Molecular Cell|May 10, 2011
Histone methylation by PRC2 is inhibited by active chromatin marksFrank W Schmitges, Archana B Prusty, Mahamadou Faty, et al.
Nature Communications|October 17, 2015
Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53Qi Fei, Ke Shang, Jianhua Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 5, 2025
Discovery of a Potent and Selective TEAD Degrader with Durable Degradation ActivityLinhui Cao, Jing Yang, Yuhang Liu, et al.
Plos One|January 11, 2017
Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EEDLing Li, Hailong Zhang, Man Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferationWei Qi, HoMan Chan, Lin Teng, et al.
Cancer Research|August 28, 2013
NSD2 is recruited through its PHD domain to oncogenic gene loci to drive multiple myelomaZheng Huang, Haiping Wu, Shannon Chuai, et al.
Journal of Medicinal Chemistry|December 20, 2016
Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) MethyltransferaseAndreas Lingel, Martin Sendzik, Ying Huang, et al.
Cell Research|August 5, 2024
SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinomaBisi Miao, Ling Ge, Chenxi He, et al.
Journal of Medicinal Chemistry|December 16, 2017
Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3)H Ümit Kaniskan, Mohammad S Eram, Kehao Zhao, et al.
Angewandte Chemie (International Ed. in English)|March 3, 2015
A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)H Ümit Kaniskan, Magdalena M Szewczyk, Zhengtian Yu, et al.
Pageof 6